glp 1 drug differences glp-1 medications GLP-1 Overdose GLP-1 Drug Comparison in Diabetes
Description
Expert Opin Pharmacother (2019) 20(5):50110

40, E65E77
doi: 10.12688/f1000research.22092.1

Age-associated cholesterol reduction triggers brain insulin resistance by facilitating ligand-independent receptor activation and pathway desensitization

McGraw-Hill / Lange rxlist.com (Tragenta ) Alogliptin Trade Name: Nesina Mechanism of Action: a DPP-4 inhibitor, similar to Sitagliptin Pharmacokinetics: does not undergo significant metabolism, and is mostly excreted unchanged in the urine (76%) and feces (13%) dosage should be reduced in patients with moderate to severe renal impairment References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)

Your care team manages dosing and tolerance, reviews labs, and provides guidance on nutrition and strength to support safe, sustainable progress